0ELV.LSE Guerbet

Healthcare Commercial Services & Supplies London Exchange
12.47 EUR
Close of Nov 3, 2026
5.82 18.13
Market cap
EUR 157M
P/E
2.6x
P/B
-
ROE
-48.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 0ELV.LSE undervalued?

Graham number

The Graham number of Guerbet cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Guerbet fundamental analysis

No fundamental analysis for Guerbet yet.

Guerbet stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Guerbet

Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconnected solution; and Artirem, a gadoteric acid. The company also provides OptiStar…

Full company profile